![migvax](https://nocamels.com/wp-content/uploads/2021/06/migvax2-350x192.jpg)
Israel’s MigVax Receives $4.3M Award For Development Of Oral Vaccine
The funding is part of a $200 million CEPI program to advance the development of vaccines that provide protection against COVID-19 variants.
November 07, 2021
![Pills. Illustrative. Photo by Christina Victoria Craft on Unsplash](https://nocamels.com/wp-content/uploads/2021/07/Pills-christina-victoria-craft-WHSnkIwWpec-unsplash-350x234.jpg)
Israeli Oral COVID-19 Vaccine Set To Begin Clinical Trials In South Africa
The oral COVID-19 vaccine developed by Israel's Oramed Pharmaceuticals will be taken by 24 unvaccinated volunteers this month.
November 02, 2021
![migvax](https://nocamels.com/wp-content/uploads/2021/06/migvax2-350x192.jpg)
Israeli Oral COVID-19 Vaccine Booster Found Effective In Preclinical Trials
MigVax is ready to begin human clinical trials with its oral vaccine and is on track to market it as a booster in the next year.
June 15, 2021